Our story of Norrie Disease
We welcome guest blogger Carla Golledge, who shares her story about son Cameron who was born with Norrie disease.
Congenica funded to reduce fatal drug interactions by mapping genes
New software to reduce the number of adverse drug reactions is being developed thanks to a joint investment of £2 million provided by UKRI and L& G.
The challenges and opportunities for growth during a global pandemic
Congenica's Chairman Andy Richards and CEO David Atkins join leaders from biotech / pharma sector to discuss the impact of pandemic in the last 18 months.
Enhanced whole exome analysis enables Veritas Intercontinental to solve more cases
Veritas Genetics partnered with Congenica to improve diagnostic yield & increase the efficiency, throughput and speed of analysis in diagnostic laboratory
Genomic sequencing in a prenatal setting - posters presented at ISPD
Two members of Congenica’s Clinical Interpretation Services team presented posters at the International Conference on Prenatal Diagnosis and Therapy (ISPD)
Mutual Collaboration focus for CRDN Companies Forum
Alastair Kent and Dr Charles Steward attended the virtual Cambridge Rare Disease Network (CRDN) Companies Forum Patient Group and Industry Partnering event
Helping to Further the Patient Impact of Genomics
Dr Charles Steward was interviewed for podcast, Once Upon a Gene, where Effie speaks to others about their journey through life with rare disease.
How Schinzel-Giedion Syndrome (SGS) has changed our lives
Nuala Summerfield tells the story of her daughter's diagnosis of rare disease Schinzel-Giedion Syndrome (SGS) and setting up The SGS Foundation
Congenica named in UK’s Digital Health Playbook - ‘First 100’ Companies
Congenica has been featured in the UK’s Digital Health Playbook ‘First 100’ as one of the UK’s most innovative and impactful digital health companies.
Genome UK implementation plan
Congenica response to Genome UK implementation plan
Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust
Congenica's Dr Charles Steward joins the “friends” of the UK infantile Spasms Trust as an advocate and advisor
Improved Next Generation Sequencing for Ultrasound Abnormalities (INGENIOUS)
At the Curating the Clinical Genome event in May 2021, Suzanne Drury, Lead Transitional Scientist, Prenatal Genomics and Personalized Health at Congenica presented a poster that detailed ...